Literature DB >> 2680971

Interleukin-6 induced at mucosal surfaces by gram-negative bacterial infection.

P de Man1, C van Kooten, L Aarden, I Engberg, H Linder, C Svanborg Edén.   

Abstract

Interleukin-6 (IL-6) was produced in response to mucosal and systemic infection of mice with gram-negative bacteria. The IL-6 response was controlled by the lipopolysaccharide gene, Lps; in C3H/HeN mice (Lpsn/Lpsn), the urinary IL-6 levels increased within 30 min after challenge with Escherichia coli, but no response occurred in C3H/HeJ mice (Lpsd/Lpsd). In lipopolysaccharide-responder mice, the levels of local and systemic IL-6 were related to the degree of infection. The urinary response dominated after intravesical challenge, and the serum response dominated after intraperitoneal challenge. The results demonstrate that IL-6 is activated as part of lipopolysaccharide-induced mucosal and systemic responses to gram-negative bacterial infections.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2680971      PMCID: PMC259830          DOI: 10.1128/iai.57.11.3383-3388.1989

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  28 in total

1.  Interleukin 1-dependent induction of both interleukin 2 secretion and interleukin 2 receptor expression by thymoma cells.

Authors:  J W Lowenthal; J C Cerottini; H R MacDonald
Journal:  J Immunol       Date:  1986-08-15       Impact factor: 5.422

2.  Multiple actions of interleukin 6 within a cytokine network.

Authors:  G G Wong; S C Clark
Journal:  Immunol Today       Date:  1988-05

3.  T cell growth factor: parameters of production and a quantitative microassay for activity.

Authors:  S Gillis; M M Ferm; W Ou; K A Smith
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

Review 4.  Bacterial endotoxins: chemical structure, biological activity and role in septicaemia.

Authors:  E T Rietschel; U Schade; M Jensen; H W Wollenweber; O Lüderitz; S G Greisman
Journal:  Scand J Infect Dis Suppl       Date:  1982

5.  Production of a monoclonal antibody to and molecular characterization of B-cell stimulatory factor-1.

Authors:  J Ohara; W E Paul
Journal:  Nature       Date:  1985 May 23-29       Impact factor: 49.962

6.  Inhibition of experimental ascending urinary tract infection by an epithelial cell-surface receptor analogue.

Authors:  C S Edén; R Freter; L Hagberg; R Hull; S Hull; H Leffler; G Schoolnik
Journal:  Nature       Date:  1982-08-05       Impact factor: 49.962

7.  Difference in susceptibility to gram-negative urinary tract infection between C3H/HeJ and C3H/HeN mice.

Authors:  L Hagberg; R Hull; S Hull; J R McGhee; S M Michalek; C Svanborg Edén
Journal:  Infect Immun       Date:  1984-12       Impact factor: 3.441

8.  Ascending, unobstructed urinary tract infection in mice caused by pyelonephritogenic Escherichia coli of human origin.

Authors:  L Hagberg; I Engberg; R Freter; J Lam; S Olling; C Svanborg Edén
Journal:  Infect Immun       Date:  1983-04       Impact factor: 3.441

9.  Cachectin/tumor necrosis factor: production, distribution, and metabolic fate in vivo.

Authors:  B A Beutler; I W Milsark; A Cerami
Journal:  J Immunol       Date:  1985-12       Impact factor: 5.422

10.  Release of an endogenous pyrogen in vitro from rabbit mononuclear cells.

Authors:  E Atkins; P Bodel; L Francis
Journal:  J Exp Med       Date:  1967-08-01       Impact factor: 14.307

View more
  51 in total

1.  Antimicrobial activity of intraurethrally administered probiotic Lactobacillus casei in a murine model of Escherichia coli urinary tract infection.

Authors:  T Asahara; K Nomoto; M Watanuki; T Yokokura
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

2.  Pharmacologic Basis for the Treatment of Pyelonephritis.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-10       Impact factor: 3.725

Review 3.  Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection.

Authors:  Thomas J Hannan; Makrina Totsika; Kylie J Mansfield; Kate H Moore; Mark A Schembri; Scott J Hultgren
Journal:  FEMS Microbiol Rev       Date:  2012-05       Impact factor: 16.408

4.  Chlamydia trachomatis pneumonia induces in vivo production of interleukin-1 and -6.

Authors:  D M Magee; J G Smith; C A Bleicker; C J Carter; L F Bonewald; J Schachter; D M Williams
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

5.  Streptococcus suis serotype 2 interactions with human brain microvascular endothelial cells.

Authors:  N Charland; V Nizet; C E Rubens; K S Kim; S Lacouture; M Gottschalk
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

Review 6.  Consequences of microbial attachment: directing host cell functions with adhesins.

Authors:  A I Hoepelman; E I Tuomanen
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

7.  Impaired cytokine expression, neutrophil infiltration and bacterial clearance in response to urinary tract infection in diabetic mice.

Authors:  Ahmet Ozer; Cengiz Z Altuntas; Fuat Bicer; Kenan Izgi; Scott J Hultgren; Guiming Liu; Firouz Daneshgari
Journal:  Pathog Dis       Date:  2015-02-05       Impact factor: 3.166

8.  IL-6-mediated signaling pathways limit Chlamydia muridarum infection and exacerbate its pathogenicity in the mouse genital tract.

Authors:  Xin Sun; Qi Tian; Luying Wang; Min Xue; Guangming Zhong
Journal:  Microbes Infect       Date:  2017-08-31       Impact factor: 2.700

9.  Uroepithelial cells are part of a mucosal cytokine network.

Authors:  S Hedges; W Agace; M Svensson; A C Sjögren; M Ceska; C Svanborg
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

10.  Local cytokine production in a murine model of Escherichia coli pyelonephritis.

Authors:  H S Rugo; P O'Hanley; A G Bishop; M K Pearce; J S Abrams; M Howard; A O'Garra
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.